Metformin pretreatment suppresses alterations to the articular cartilage ultrastructure and knee joint tissue damage secondary to type 2 diabetes mellitus in rats

References

• Grazio S, Balen D. [Obesity: risk factor and predictor of osteoarthritis]. Lijec Vjesn. 2009;131:22–26.
   PubMedGoogle Scholar
• Scanzello CR, Goldring SR. The role of synovitis in osteoarthritis pathogenesis. Bone. 2012;51(2):249–257. doi:10.1016/j.bone.2012.02.012.
   PubMed Web of Science ®Google Scholar
• Hayami T. [Osteoarthritis of the knee joint as a cause of musculoskeletal ambulation disability symptom complex (MADS)]. Clin Calcium. 2008;18(11):1574–1580.
   PubMedGoogle Scholar
• Van Manen MD, Nace J, Mont MA. Management of primary knee osteoarthritis and indications for total knee arthroplasty for general practitioners. J Am Osteopath Assoc. 2012;112:709–715.
   PubMedGoogle Scholar
• Pottie P, Presle N, Terlain B, Netter P, Mainard D, Berenbaum F. Obesity and osteoarthritis: more complex than predicted! Ann Rheum Dis. 2006 Nov;65(11):1403–1405. doi:10.1136/ard.2006.061994.
   PubMed Web of Science ®Google Scholar
• Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest. 2006;116(7):1793–1801. doi:10.1172/JCI29069.
   PubMed Web of Science ®Google Scholar
• Berenbaum F. Diabetes-induced osteoarthritis: from a new paradigm to a new phenotype. Postgrad Med J. 2012;88(1038):240–242. doi:10.1136/pgmj.2010.146399rep.
   PubMed Web of Science ®Google Scholar
• Vistoli G, De Maddis D, Cipak A, Zarkovic N, Carini M, Aldini G. Advanced glycoxidation and lipoxidation end products (AGEs and ALEs): an overview of their mechanisms of formation. Free Radic Res. 2013;47(Suppl 1):3–27. doi:10.3109/10715762.2013.815348.
   PubMed Web of Science ®Google Scholar
• Moussa SA. Oxidative stress in diabetes mellitus. Romanian. J Biophys. 2008;18:225–236.
   Google Scholar
• Cicero AF, Tartagni E, Ertek S. Metformin and its clinical use: new insights for an old drug in clinical practice. Arch Med Sci. 2012;8(5):907–917. doi:10.5114/aoms.2012.31622.
   PubMed Web of Science ®Google Scholar
• Al-Hashem F, Al-Humayed S, Amin SN, et al. Metformin inhibits mTOR-HIF-1alpha axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. J Cell Physiol. 2019;234(6):9328–9337. doi:10.1002/jcp.27616.
   PubMed Web of Science ®Google Scholar
• Al-Hashem F, AlHumayed S, Ellatif MA, et al. Metformin protects against thioacetamide induced liver injury in rats. Int J Morphol. 2018;36(3):984–990. doi:10.4067/S0717-95022018000300984.
   Web of Science ®Google Scholar
• Lachin JM, Viberti G, Zinman B, et al. Renal function in type 2 diabetes with rosiglitazone, metformin, and glyburide monotherapy. Clin J Am Soc Nephrol. 2011;6(5):1032–1040. doi:10.2215/CJN.09291010.
   PubMed Web of Science ®Google Scholar
• Amini FG, Rafieian-Kopaei M, Nematbakhsh M, Baradaran A, Nasri H. Ameliorative effects of metformin on renal histologic and biochemical alterations of gentamicin-induced renal toxicity in Wistar rats. J Res Med Sci. 2012;17:621–625.
   PubMed Web of Science ®Google Scholar
• Conde de la Rosa L, Vrenken TE, Buist-Homan M, Faber KN, Moshage H. Metformin protects primary rat hepatocytes against oxidative stress-induced apoptosis. Pharmacol Res Perspect. 2015;3:18.
   Web of Science ®Google Scholar
• Al-Hashem F, Al-Humayed S, Amin SN, et al. Metformin inhibits mTOR-HIF-1alpha axis and profibrogenic and inflammatory biomarkers in thioacetamide-induced hepatic tissue alterations. J Cell Physiol. 2018;18(10):27616.
   Google Scholar
• Matafome P, Louro T, Rodrigues L, et al. Metformin and atorvastatin combination further protect the liver in type 2 diabetes with hyperlipidaemia. Diabetes Metab Res Rev. 2011;27(1):54–62. doi:10.1002/dmrr.1157.
   PubMed Web of Science ®Google Scholar
• Liu Y, Jiang X, Chen X. Liraglutide and metformin alone or combined therapy for type 2 diabetes patients complicated with coronary artery disease. Lipids Health Dis. 2017;16(1):227. doi:10.1186/s12944-017-0609-0.
   PubMed Web of Science ®Google Scholar
• Dallak M, Haidara MA, Bin-Jaliah I, et al. Metformin suppresses aortic ultrastructural damage and hypertension induced by diabetes: a potential role of advanced glycation end products. Ultrastruct Pathol. 2019;15:1–9.
   Google Scholar
• Jenkins AJ, Welsh P, Petrie JR. Metformin, lipids and atherosclerosis prevention. Curr Opin Lipidol. 2018;29(4):346–353. doi:10.1097/MOL.0000000000000532.
   PubMed Web of Science ®Google Scholar
• Dziubak A, Wójcicka G, Wojtak A, Bełtowski J. Metabolic effects of metformin in the failing heart. Int J Mol Sci. 2018;19:2869.
   PubMed Web of Science ®Google Scholar
• Wang C, Yang Y, Zhang Y, Liu J, Yao Z, Zhang C. Protective effects of metformin against osteoarthritis through upregulation of SIRT3-mediated PINK1/Parkin-dependent mitophagy in primary chondrocytes. Biosci Trends. 2019;12(6):605–612. doi:10.5582/bst.2018.01263.
   PubMed Web of Science ®Google Scholar
• Collino M, Aragno M, Castiglia S, et al. Pioglitazone improves lipid and insulin levels in overweight rats on a high cholesterol and fructose diet by decreasing hepatic inflammation. Br J Pharmacol. 2010;160(8):1892–1902. doi:10.1111/j.1476-5381.2010.00671.x.
   PubMed Web of Science ®Google Scholar
• Pritzker KP, Gay S, Jimenez SA, et al. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage. 2006;14(1):13–29. doi:10.1016/j.joca.2005.07.014.
   PubMed Web of Science ®Google Scholar
• Onur T, Wu R, Metz L, Dang A. Characterisation of osteoarthritis in a small animal model of type 2 diabetes mellitus. Bone Joint Res. 2014;3(6):203–211. doi:10.1302/2046-3758.36.2000244.
   PubMed Web of Science ®Google Scholar
• Malemud CJ. Changes in proteoglycans in osteoarthritis: biochemistry, ultrastructure and biosynthetic processing. J Rheumat Suppl. 1991;27:60–62.
   PubMedGoogle Scholar
• Al-Hashem F, El Karib AO, Bin-Jaliah I, et al. Exercise protects against insulin-dependent diabetes-induced osteoarthritis in rats: A scanning electron microscopy study. Ultrastruct Pathol. 2017;41(3):252–257. doi:10.1080/01913123.2017.1313346.
   PubMed Web of Science ®Google Scholar
• Perez Vertti RDA, Muniz LSA, Martinez JM, Galarza FFG, Astorga RA. Cartilage oligomeric matrix protein levels in type 2 diabetes associated with primary knee osteoarthritis patients. Genet Test Mol Biomarkers. 2018;8:10.
   Google Scholar
• El Karib AO, Al-Ani B, Al-Hashem F, et al. Insulin and vanadium protect against osteoarthritis development secondary to diabetes mellitus in rats. Arch Physiol Biochem. 2016;122(3):148–154. doi:10.3109/13813455.2016.1159698.
   PubMed Web of Science ®Google Scholar
• Adeyemi WJ, Olayaki LA. Diabetes escalates knee osteoarthritis in rats: evidence of adaptive mechanism. Environ Toxicol Pharmacol. 2018;61:1–7. doi:10.1016/j.etap.2018.05.009.
   PubMed Web of Science ®Google Scholar
• El Hassan A, Ba-Amah H, Al Faya FF, Sahraewn H. Development of a rat model of knee osteoarthritis by a combination of monoiodoacetate and streptozotocin. Int J Morphol. 2017;35(4):1383–1390. doi:10.4067/S0717-95022017000401383.
   Web of Science ®Google Scholar
• Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations. Ther Adv Musculoskelet Dis. 2013;5(2):77–94. doi:10.1177/1759720X12467868.
   PubMedGoogle Scholar
• Eyre D. Collagen of articular cartilage. Arthritis Res. 2002;4(1):30–35. doi:10.1186/ar380.
   PubMedGoogle Scholar
• Buckwalter JA, Mankin HJ, Grodzinsky AJ Articular cartilage and osteoarthritis. Instructional course lectures. 2005;54:465–480.
   Google Scholar
• Lian C, Wang X, Qiu X, et al. Collagen type II suppresses articular chondrocyte hypertrophy and osteoarthritis progression by promoting integrin beta1-SMAD1 interaction. Bone Res. 2019;7(8):019–0046. doi:10.1038/s41413-019-0046-y.
   PubMed Web of Science ®Google Scholar
• Lu W, Ding Z, Liu F, et al. Dopamine delays articular cartilage degradation in osteoarthritis by negative regulation of the NF-kappaB and JAK2/STAT3 signaling pathways. Biomed Pharmacother. 2019;119(109419):25. doi:10.1016/j.biopha.2019.109419.
   Web of Science ®Google Scholar
• Vikkula M, Metsaranta M, Ala-Kokko L. Type II collagen mutations in rare and common cartilage diseases. Ann Med. 1994;26(2):107–114. doi:10.3109/07853899409147337.
   PubMed Web of Science ®Google Scholar
• Kalaitzoglou E, Popescu I, Bunn RC, Fowlkes JL, Thrailkill KM. Effects of type 1 diabetes on osteoblasts, osteocytes, and osteoclasts. Curr Osteoporos Rep. 2016;14(6):310–319. doi:10.1007/s11914-016-0329-9.
   PubMed Web of Science ®Google Scholar
• Wang Y, Hussain SM, Wluka AE, et al. Association between metformin use and disease progression in obese people with knee osteoarthritis: data from the Osteoarthritis Initiative-a prospective cohort study. Arthritis Res Ther. 2019;21(1):019–1915. doi:10.1186/s13075-019-1915-x.
   PubMed Web of Science ®Google Scholar